CCKAR (cholecystokinin A receptor) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: CCKAR (cholecystokinin A receptor) Homo sapiens
Analyze
Symbol: CCKAR
Name: cholecystokinin A receptor
RGD ID: 731770
HGNC Page HGNC:1570
Description: Enables cholecystokinin receptor activity and peptide hormone binding activity. Involved in cholecystokinin signaling pathway. Located in cytosol; nucleoplasm; and plasma membrane. Implicated in obesity. Biomarker of cholelithiasis; pancreatic cancer; and pancreatic ductal carcinoma.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: CCK-1R; CCK-A; CCK-A receptor; CCK-AR; CCK1-R; CCK1R; CCKRA; cholecystokinin receptor type A; cholecystokinin type 1 receptor; cholecystokinin type-A receptor; cholecystokinin-1 receptor
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Orthologs
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38426,481,396 - 26,490,484 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl426,481,396 - 26,490,484 (-)EnsemblGRCh38hg38GRCh38
GRCh37426,483,018 - 26,492,106 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36426,092,116 - 26,101,140 (-)NCBINCBI36Build 36hg18NCBI36
Build 34426,159,286 - 26,168,311NCBI
Celera426,934,075 - 26,943,099 (-)NCBICelera
Cytogenetic Map4p15.2NCBI
HuRef425,821,291 - 25,830,315 (-)NCBIHuRef
CHM1_1426,484,379 - 26,493,404 (-)NCBICHM1_1
T2T-CHM13v2.0426,466,670 - 26,475,758 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component
cytosol  (IDA)
endosome  (ISO)
membrane  (IDA,IEA)
nucleoplasm  (IDA)
plasma membrane  (IDA,IEA,TAS)
terminal bouton  (ISO)

Molecular Function

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
References

References - curated
# Reference Title Reference Citation
1. Correlation between gene expression of CCK-A receptor and emptying dysfunction of the gallbladder in patients with gallstones and diabetes mellitus. Ding X, etal., Hepatobiliary Pancreat Dis Int. 2005 May;4(2):295-8.
2. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
3. Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM). Inoue H, etal., Genomics 1997 Jun 1;42(2):331-5.
4. Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer. Moonka R, etal., J Gastrointest Surg. 1999 Mar-Apr;3(2):134-40.
5. Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors. Moran TH and Bi S, Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1211-8.
6. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Moran TH, etal., Am J Physiol. 1998 Mar;274(3 Pt 2):R618-25.
7. Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue. Reubi JC, etal., Gastroenterology. 2003 Jul;125(1):98-106.
8. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
9. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
10. Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease. Wang J, etal., Pharmacogenetics. 2003 Jun;13(6):365-9.
11. The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia. Wei J and Hemmings GP, Eur Psychiatry 1999 Apr;14(2):67-70.
12. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. Weinberg DS, etal., J Clin Invest. 1997 Aug 1;100(3):597-603.
13. Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma. Zhou W, etal., Carcinogenesis. 1993 Oct;14(10):2189-92.
Additional References at PubMed
PMID:7557108   PMID:7759110   PMID:8343165   PMID:8503909   PMID:9006937   PMID:9603948   PMID:10026437   PMID:10400673   PMID:10555959   PMID:10595537   PMID:10682840   PMID:10893485  
PMID:11300760   PMID:11368834   PMID:11495676   PMID:11549403   PMID:11730982   PMID:12198366   PMID:12424565   PMID:12477932   PMID:12627462   PMID:12801592   PMID:14534299   PMID:14691070  
PMID:15100163   PMID:15108185   PMID:15313848   PMID:15340101   PMID:15363473   PMID:15489334   PMID:15632187   PMID:15634012   PMID:15723764   PMID:15740988   PMID:15786550   PMID:15927089  
PMID:16362631   PMID:16754659   PMID:17413443   PMID:17413452   PMID:17457313   PMID:17597711   PMID:17944886   PMID:18444993   PMID:18577758   PMID:18583979   PMID:18776046   PMID:18832011  
PMID:18996102   PMID:19086053   PMID:19751565   PMID:19753663   PMID:19760980   PMID:19874574   PMID:19913121   PMID:20023595   PMID:20351714   PMID:20424473   PMID:20468064   PMID:20535329  
PMID:20538960   PMID:20558763   PMID:20602615   PMID:20628086   PMID:20732371   PMID:21728335   PMID:21813391   PMID:21873635   PMID:22021636   PMID:22396142   PMID:22825913   PMID:23341962  
PMID:23701593   PMID:24825903   PMID:24914377   PMID:25025063   PMID:25875176   PMID:26508021   PMID:26551933   PMID:26608796   PMID:27072272   PMID:27287528   PMID:33050050   PMID:34086670  
PMID:34556862   PMID:39083706  


Genomics

Comparative Map Data
CCKAR
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38426,481,396 - 26,490,484 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl426,481,396 - 26,490,484 (-)EnsemblGRCh38hg38GRCh38
GRCh37426,483,018 - 26,492,106 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36426,092,116 - 26,101,140 (-)NCBINCBI36Build 36hg18NCBI36
Build 34426,159,286 - 26,168,311NCBI
Celera426,934,075 - 26,943,099 (-)NCBICelera
Cytogenetic Map4p15.2NCBI
HuRef425,821,291 - 25,830,315 (-)NCBIHuRef
CHM1_1426,484,379 - 26,493,404 (-)NCBICHM1_1
T2T-CHM13v2.0426,466,670 - 26,475,758 (-)NCBIT2T-CHM13v2.0
Cckar
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39553,855,827 - 53,865,046 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl553,855,118 - 53,865,047 (-)EnsemblGRCm39 Ensembl
GRCm38553,698,485 - 53,707,704 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl553,697,776 - 53,707,705 (-)EnsemblGRCm38mm10GRCm38
MGSCv37554,089,724 - 54,098,943 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36553,986,735 - 53,996,350 (-)NCBIMGSCv36mm8
Celera551,081,684 - 51,090,889 (-)NCBICelera
Cytogenetic Map5C1NCBI
cM Map529.52NCBI
Cckar
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81461,505,270 - 61,513,618 (+)NCBIGRCr8
mRatBN7.21457,292,397 - 57,300,747 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1457,292,397 - 57,300,747 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1461,699,304 - 61,707,579 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01463,001,655 - 63,009,913 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01459,398,438 - 59,406,696 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01459,610,939 - 59,619,786 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1459,611,434 - 59,619,783 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01459,691,504 - 59,747,723 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41462,052,510 - 62,057,201 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11462,054,843 - 62,064,735 (+)NCBI
Celera1456,400,364 - 56,408,663 (+)NCBICelera
RH 3.4 Map14455.67RGD
Cytogenetic Map14q11NCBI
Cckar
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495544318,737,974 - 18,748,727 (+)EnsemblChiLan1.0
ChiLan1.0NW_00495544318,738,029 - 18,748,684 (+)NCBIChiLan1.0ChiLan1.0
CCKAR
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v2326,733,119 - 26,745,226 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan1426,924,864 - 26,936,971 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0420,881,340 - 20,890,986 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1426,157,702 - 26,166,773 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl426,157,702 - 26,166,773 (-)Ensemblpanpan1.1panPan2
CCKAR
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1384,010,700 - 84,019,066 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl384,010,205 - 84,021,293 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha386,523,114 - 86,531,436 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0384,979,595 - 84,989,334 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl384,978,882 - 84,990,505 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1384,102,638 - 84,110,963 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0384,222,497 - 84,230,820 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0384,607,068 - 84,615,397 (+)NCBIUU_Cfam_GSD_1.0
Cckar
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440528549,605,282 - 49,613,370 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049364773,306,874 - 3,314,714 (+)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_0049364773,306,898 - 3,314,659 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
CCKAR
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl820,188,830 - 20,199,344 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1820,187,324 - 20,200,273 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2820,563,652 - 20,574,944 (-)NCBISscrofa10.2Sscrofa10.2susScr3
CCKAR
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.12723,855,766 - 23,866,104 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl2723,856,705 - 23,865,367 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366604770,369,554 - 70,378,492 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Cckar
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046247556,121,620 - 6,132,897 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046247556,122,181 - 6,132,623 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in CCKAR
31 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
NM_000730.3(CCKAR):c.61G>C (p.Gly21Arg) single nucleotide variant CHOLECYSTOKININ A RECEPTOR POLYMORPHISM [RCV000019081]|not provided [RCV004715645] Chr4:26490207 [GRCh38]
Chr4:26491829 [GRCh37]
Chr4:4p15.2
benign
NM_000730.3(CCKAR):c.1093G>A (p.Val365Ile) single nucleotide variant CHOLECYSTOKININ A RECEPTOR POLYMORPHISM [RCV000019082]|not provided [RCV004715646] Chr4:26481832 [GRCh38]
Chr4:26481832..26481833 [GRCh38]
Chr4:26483454 [GRCh37]
Chr4:26483454..26483455 [GRCh37]
Chr4:4p15.2
benign
NM_000730.2(CCKAR):c.365-1571T>C single nucleotide variant Lung cancer [RCV000094597] Chr4:26487469 [GRCh38]
Chr4:26489091 [GRCh37]
Chr4:4p15.2
uncertain significance
GRCh38/hg38 4p16.3-15.1(chr4:72555-28066309)x1 copy number loss See cases [RCV000051642] Chr4:72555..28066309 [GRCh38]
Chr4:72447..28067931 [GRCh37]
Chr4:62447..27677029 [NCBI36]
Chr4:4p16.3-15.1
pathogenic
GRCh38/hg38 4p16.3-15.2(chr4:51519-26519788)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051752]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051752]|See cases [RCV000051752] Chr4:51519..26519788 [GRCh38]
Chr4:51413..26521410 [GRCh37]
Chr4:41413..26130508 [NCBI36]
Chr4:4p16.3-15.2
pathogenic
GRCh38/hg38 4p16.3-15.1(chr4:72555-33130620)x3 copy number gain See cases [RCV000051753] Chr4:72555..33130620 [GRCh38]
Chr4:72447..33132242 [GRCh37]
Chr4:62447..32808637 [NCBI36]
Chr4:4p16.3-15.1
pathogenic
GRCh38/hg38 4p16.3-14(chr4:85149-38700366)x3 copy number gain See cases [RCV000051757] Chr4:85149..38700366 [GRCh38]
Chr4:85040..38701987 [GRCh37]
Chr4:75040..38378382 [NCBI36]
Chr4:4p16.3-14
pathogenic
GRCh38/hg38 4p15.31-15.2(chr4:21056309-26732162)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053263]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053263]|See cases [RCV000053263] Chr4:21056309..26732162 [GRCh38]
Chr4:21057932..26733784 [GRCh37]
Chr4:20667030..26342882 [NCBI36]
Chr4:4p15.31-15.2
pathogenic
GRCh38/hg38 4p16.3-14(chr4:72555-39477144)x3 copy number gain See cases [RCV000133677] Chr4:72555..39477144 [GRCh38]
Chr4:72447..39478764 [GRCh37]
Chr4:62447..39155159 [NCBI36]
Chr4:4p16.3-14
pathogenic
GRCh38/hg38 4p15.2(chr4:23862000-27685546)x1 copy number loss See cases [RCV000135404] Chr4:23862000..27685546 [GRCh38]
Chr4:23863623..27687168 [GRCh37]
Chr4:23472721..27296266 [NCBI36]
Chr4:4p15.2
pathogenic
GRCh38/hg38 4p15.32-15.1(chr4:16925022-32113076)x1 copy number loss See cases [RCV000135806] Chr4:16925022..32113076 [GRCh38]
Chr4:16926645..32114698 [GRCh37]
Chr4:16535743..31758596 [NCBI36]
Chr4:4p15.32-15.1
pathogenic|likely pathogenic
GRCh38/hg38 4p16.3-12(chr4:36424-47491595)x3 copy number gain See cases [RCV000137261] Chr4:36424..47491595 [GRCh38]
Chr4:36424..47493612 [GRCh37]
Chr4:26424..47188369 [NCBI36]
Chr4:4p16.3-12
pathogenic
GRCh37/hg19 4p16.3-15.1(chr4:71552-29006745)x1 copy number loss See cases [RCV000240003] Chr4:71552..29006745 [GRCh37]
Chr4:4p16.3-15.1
pathogenic
GRCh37/hg19 4p16.3-11(chr4:12440-49064044)x3 copy number gain See cases [RCV000240562] Chr4:12440..49064044 [GRCh37]
Chr4:4p16.3-11
pathogenic
GRCh37/hg19 4p16.3-11(chr4:68345-49089361)x3 copy number gain not specified [RCV003986479] Chr4:68345..49089361 [GRCh37]
Chr4:4p16.3-11
pathogenic
GRCh37/hg19 4p15.2-15.1(chr4:23458442-29252060)x1 copy number loss See cases [RCV000240221] Chr4:23458442..29252060 [GRCh37]
Chr4:4p15.2-15.1
pathogenic
GRCh37/hg19 4p16.3-11(chr4:68345-49089361)x3 copy number gain See cases [RCV002292704] Chr4:68345..49089361 [GRCh37]
Chr4:4p16.3-11
pathogenic
GRCh37/hg19 4p16.3-11(chr4:68345-49093788)x3 copy number gain See cases [RCV000446451] Chr4:68345..49093788 [GRCh37]
Chr4:4p16.3-11
pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:12440-190904441)x3 copy number gain See cases [RCV000446653] Chr4:12440..190904441 [GRCh37]
Chr4:4p16.3-q35.2
pathogenic
GRCh37/hg19 4p15.2-15.1(chr4:23790131-32302608)x1 copy number loss See cases [RCV000445756] Chr4:23790131..32302608 [GRCh37]
Chr4:4p15.2-15.1
likely pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:68346-190957473) copy number gain See cases [RCV000510453] Chr4:68346..190957473 [GRCh37]
Chr4:4p16.3-q35.2
pathogenic
GRCh37/hg19 4p16.3-q13.1(chr4:68345-66440622)x3 copy number gain See cases [RCV000511193] Chr4:68345..66440622 [GRCh37]
Chr4:4p16.3-q13.1
pathogenic
NM_000730.3(CCKAR):c.1202G>A (p.Gly401Glu) single nucleotide variant not specified [RCV004325115] Chr4:26481723 [GRCh38]
Chr4:26483345 [GRCh37]
Chr4:4p15.2
uncertain significance
GRCh37/hg19 4p16.3-q35.2(chr4:68346-190957473)x3 copy number gain See cases [RCV000512241] Chr4:68346..190957473 [GRCh37]
Chr4:4p16.3-q35.2
pathogenic
GRCh37/hg19 4p16.3-11(chr4:68345-49089361)x3 copy number gain not provided [RCV000682363] Chr4:68345..49089361 [GRCh37]
Chr4:4p16.3-11
pathogenic
GRCh37/hg19 4p16.3-15.1(chr4:4165334-33324781)x1 copy number loss not provided [RCV000682373] Chr4:4165334..33324781 [GRCh37]
Chr4:4p16.3-15.1
pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:49450-190915650)x3 copy number gain not provided [RCV000743155] Chr4:49450..190915650 [GRCh37]
Chr4:4p16.3-q35.2
pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:49450-190963766)x3 copy number gain not provided [RCV000743156] Chr4:49450..190963766 [GRCh37]
Chr4:4p16.3-q35.2
pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:11525-191028879)x3 copy number gain not provided [RCV000743147] Chr4:11525..191028879 [GRCh37]
Chr4:4p16.3-q35.2
pathogenic
GRCh37/hg19 4p16.3-11(chr4:1356924-49659859)x3 copy number gain not provided [RCV000743201] Chr4:1356924..49659859 [GRCh37]
Chr4:4p16.3-11
pathogenic
NM_000730.3(CCKAR):c.651C>T (p.Leu217=) single nucleotide variant not provided [RCV000937755] Chr4:26483259 [GRCh38]
Chr4:26484881 [GRCh37]
Chr4:4p15.2
likely benign
GRCh37/hg19 4p15.33-15.1(chr4:12778849-27760141) copy number loss not provided [RCV000767707] Chr4:12778849..27760141 [GRCh37]
Chr4:4p15.33-15.1
pathogenic
GRCh37/hg19 4p16.3-15.2(chr4:68345-27423424)x3 copy number gain not provided [RCV001005510] Chr4:68345..27423424 [GRCh37]
Chr4:4p16.3-15.2
pathogenic
GRCh37/hg19 4p15.31-15.1(chr4:20406475-29134345)x1 copy number loss not provided [RCV001005527] Chr4:20406475..29134345 [GRCh37]
Chr4:4p15.31-15.1
pathogenic
GRCh37/hg19 4p15.2(chr4:26326650-27059065)x3 copy number gain not provided [RCV001259841] Chr4:26326650..27059065 [GRCh37]
Chr4:4p15.2
uncertain significance
GRCh37/hg19 4p16.3-15.1(chr4:69671-29702595)x3 copy number gain not provided [RCV001537928] Chr4:69671..29702595 [GRCh37]
Chr4:4p16.3-15.1
pathogenic
GRCh37/hg19 4p15.2-15.1(chr4:23790131-32302608) copy number loss not specified [RCV002053411] Chr4:23790131..32302608 [GRCh37]
Chr4:4p15.2-15.1
likely pathogenic
GRCh37/hg19 4p15.31-14(chr4:19892850-37325128) copy number loss not specified [RCV002053409] Chr4:19892850..37325128 [GRCh37]
Chr4:4p15.31-14
pathogenic
GRCh37/hg19 4p16.3-12(chr4:114784-47569569)x3 copy number gain FETAL DEMISE [RCV002282978] Chr4:114784..47569569 [GRCh37]
Chr4:4p16.3-12
pathogenic
NM_000730.3(CCKAR):c.893G>T (p.Ser298Ile) single nucleotide variant not specified [RCV004214095] Chr4:26482032 [GRCh38]
Chr4:26483654 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.1099C>A (p.Pro367Thr) single nucleotide variant not specified [RCV004129338] Chr4:26481826 [GRCh38]
Chr4:26483448 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.524C>T (p.Pro175Leu) single nucleotide variant not specified [RCV004194688] Chr4:26485739 [GRCh38]
Chr4:26487361 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.68A>G (p.Glu23Gly) single nucleotide variant not specified [RCV004135075] Chr4:26490200 [GRCh38]
Chr4:26491822 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.425C>T (p.Ala142Val) single nucleotide variant not specified [RCV004074306] Chr4:26485838 [GRCh38]
Chr4:26487460 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.632C>G (p.Thr211Arg) single nucleotide variant not specified [RCV004121521] Chr4:26483278 [GRCh38]
Chr4:26484900 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.570C>A (p.Asn190Lys) single nucleotide variant not specified [RCV004146431] Chr4:26485693 [GRCh38]
Chr4:26487315 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.1021G>A (p.Ala341Thr) single nucleotide variant not specified [RCV004241719] Chr4:26481904 [GRCh38]
Chr4:26483526 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.575C>T (p.Thr192Ile) single nucleotide variant not specified [RCV004231826] Chr4:26485688 [GRCh38]
Chr4:26487310 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.799G>A (p.Asp267Asn) single nucleotide variant not specified [RCV004189847] Chr4:26482126 [GRCh38]
Chr4:26483748 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.694A>G (p.Ile232Val) single nucleotide variant not specified [RCV004168394] Chr4:26483216 [GRCh38]
Chr4:26484838 [GRCh37]
Chr4:4p15.2
uncertain significance
GRCh38/hg38 4p15.33-14(chr4:11399082-38137335) copy number loss 4p partial monosomy syndrome [RCV003155905] Chr4:11399082..38137335 [GRCh38]
Chr4:4p15.33-14
pathogenic
NM_000730.3(CCKAR):c.796A>G (p.Ser266Gly) single nucleotide variant not specified [RCV004252177] Chr4:26482129 [GRCh38]
Chr4:26483751 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.1085C>A (p.Ser362Tyr) single nucleotide variant not specified [RCV004272654] Chr4:26481840 [GRCh38]
Chr4:26483462 [GRCh37]
Chr4:4p15.2
uncertain significance
GRCh37/hg19 4p16.3-15.1(chr4:68345-34512694) copy number gain 4p16.3 microduplication syndrome [RCV003319592] Chr4:68345..34512694 [GRCh37]
Chr4:4p16.3-15.1
pathogenic
GRCh38/hg38 4p16.3-q12(chr4:85624-57073230)x3 copy number gain Neurodevelopmental disorder [RCV003327613] Chr4:85624..57073230 [GRCh38]
Chr4:4p16.3-q12
pathogenic
GRCh38/hg38 4p16.3-11(chr4:1-49062177)x3 copy number gain Neurodevelopmental disorder [RCV003327611] Chr4:1..49062177 [GRCh38]
Chr4:4p16.3-11
pathogenic
GRCh38/hg38 4p16.3-13(chr4:2904667-42963232)x3 copy number gain Neurodevelopmental disorder [RCV003327612] Chr4:2904667..42963232 [GRCh38]
Chr4:4p16.3-13
pathogenic
NM_000730.3(CCKAR):c.979A>G (p.Met327Val) single nucleotide variant not specified [RCV004346454] Chr4:26481946 [GRCh38]
Chr4:26483568 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.379G>A (p.Val127Ile) single nucleotide variant not specified [RCV004359051] Chr4:26485884 [GRCh38]
Chr4:26487506 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.353C>T (p.Thr118Ile) single nucleotide variant not specified [RCV004430514] Chr4:26489244 [GRCh38]
Chr4:26490866 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.1262T>A (p.Met421Lys) single nucleotide variant not specified [RCV004430511] Chr4:26481663 [GRCh38]
Chr4:26483285 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.796A>T (p.Ser266Cys) single nucleotide variant not specified [RCV004430516] Chr4:26482129 [GRCh38]
Chr4:26483751 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.109A>G (p.Lys37Glu) single nucleotide variant not specified [RCV004430510] Chr4:26490159 [GRCh38]
Chr4:26491781 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.163A>G (p.Ser55Gly) single nucleotide variant not specified [RCV004430512] Chr4:26489434 [GRCh38]
Chr4:26491056 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.284T>C (p.Met95Thr) single nucleotide variant not specified [RCV004430513] Chr4:26489313 [GRCh38]
Chr4:26490935 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.994G>A (p.Ala332Thr) single nucleotide variant not specified [RCV004430517] Chr4:26481931 [GRCh38]
Chr4:26483553 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.999C>A (p.Asn333Lys) single nucleotide variant not specified [RCV004430518] Chr4:26481926 [GRCh38]
Chr4:26483548 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.449G>C (p.Arg150Pro) single nucleotide variant not specified [RCV004430515] Chr4:26485814 [GRCh38]
Chr4:26487436 [GRCh37]
Chr4:4p15.2
uncertain significance
NC_000004.11:g.(?_25125553)_(26492222_?)dup duplication not provided [RCV004580842] Chr4:25125553..26492222 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.265A>G (p.Met89Val) single nucleotide variant not specified [RCV004604749] Chr4:26489332 [GRCh38]
Chr4:26490954 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.950T>C (p.Val317Ala) single nucleotide variant not specified [RCV004604748] Chr4:26481975 [GRCh38]
Chr4:26483597 [GRCh37]
Chr4:4p15.2
uncertain significance
NM_000730.3(CCKAR):c.1034G>A (p.Arg345His) single nucleotide variant not specified [RCV004335568] Chr4:26481891 [GRCh38]
Chr4:26483513 [GRCh37]
Chr4:4p15.2
uncertain significance
GRCh37/hg19 4p15.2(chr4:26431386-26489057)x3 copy number gain not provided [RCV000743456] Chr4:26431386..26489057 [GRCh37]
Chr4:4p15.2
benign
GRCh37/hg19 4p16.3-12(chr4:49450-46339070)x3 copy number gain not provided [RCV000743154] Chr4:49450..46339070 [GRCh37]
Chr4:4p16.3-12
pathogenic
GRCh37/hg19 4p16.3-11(chr4:49450-49620898)x3 copy number gain See cases [RCV001194594] Chr4:49450..49620898 [GRCh37]
Chr4:4p16.3-11
pathogenic
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:259
Count of miRNA genes:219
Interacting mature miRNAs:240
Transcripts:ENST00000295589
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCh38)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
407042365GWAS691341_Hpost-traumatic stress disorder QTL GWAS691341 (human)0.000001post-traumatic stress disorder42648183226481833Human
407062908GWAS711884_Hprimary aldosteronism QTL GWAS711884 (human)0.0000006primary aldosteronism42648953426489535Human

Markers in Region
STS-L19315  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37426,483,252 - 26,483,430UniSTSGRCh37
Build 36426,092,350 - 26,092,528RGDNCBI36
Celera426,934,309 - 26,934,487RGD
Cytogenetic Map4p15.1-p15.2UniSTS
HuRef425,821,525 - 25,821,703UniSTS
GeneMap99-GB4 RH Map4107.98UniSTS
SHGC-50173  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37426,483,051 - 26,483,165UniSTSGRCh37
Build 36426,092,149 - 26,092,263RGDNCBI36
Celera426,934,108 - 26,934,222RGD
Cytogenetic Map4p15.1-p15.2UniSTS
HuRef425,821,324 - 25,821,438UniSTS
TNG Radiation Hybrid Map416348.0UniSTS
D4S3157  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37426,483,035 - 26,483,259UniSTSGRCh37
Build 36426,092,133 - 26,092,357RGDNCBI36
Celera426,934,092 - 26,934,316RGD
Cytogenetic Map4p15.1-p15.2UniSTS
HuRef425,821,308 - 25,821,532UniSTS
Stanford-G3 RH Map41601.0UniSTS
Whitehead-YAC Contig Map4 UniSTS
NCBI RH Map4282.6UniSTS
GeneMap99-G3 RH Map41585.0UniSTS


Expression

RNA-SEQ Expression

adipose tissue
alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
renal system
reproductive system
respiratory system
sensory system
167 1787 285 497 2321 429 430 152 177 30 301 1642 1505 29 2099 265 835 324 126

Sequence


Ensembl Acc Id: ENST00000295589   ⟹   ENSP00000295589
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl426,481,396 - 26,490,484 (-)Ensembl
RefSeq Acc Id: NM_000730   ⟹   NP_000721
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38426,481,396 - 26,490,484 (-)NCBI
GRCh37426,483,018 - 26,492,042 (-)ENTREZGENE
Build 36426,092,116 - 26,101,140 (-)NCBI Archive
HuRef425,821,291 - 25,830,315 (-)ENTREZGENE
CHM1_1426,484,379 - 26,493,404 (-)NCBI
T2T-CHM13v2.0426,466,670 - 26,475,758 (-)NCBI
Sequence:
RefSeq Acc Id: NP_000721   ⟸   NM_000730
- UniProtKB: B2R9Z5 (UniProtKB/Swiss-Prot),   P32238 (UniProtKB/Swiss-Prot)
- Sequence:
Ensembl Acc Id: ENSP00000295589   ⟸   ENST00000295589

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P32238-F1-model_v2 AlphaFold P32238 1-428 view protein structure

Promoters
RGD ID:6867184
Promoter ID:EPDNEW_H6757
Type:initiation region
Name:CCKAR_1
Description:cholecystokinin A receptor
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38426,490,431 - 26,490,491EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:1570 AgrOrtholog
COSMIC CCKAR COSMIC
Ensembl Genes ENSG00000163394 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENST00000295589 ENTREZGENE
  ENST00000295589.4 UniProtKB/Swiss-Prot
Gene3D-CATH 4.10.670.10 UniProtKB/Swiss-Prot
  Rhodopsin 7-helix transmembrane proteins UniProtKB/Swiss-Prot
GTEx ENSG00000163394 GTEx
HGNC ID HGNC:1570 ENTREZGENE
Human Proteome Map CCKAR Human Proteome Map
InterPro Cholcskin_rcpt UniProtKB/Swiss-Prot
  Cholcy_rcpt_A UniProtKB/Swiss-Prot
  CholecystokininA_recpt_N UniProtKB/Swiss-Prot
  CholecystokininA_recpt_N_sf UniProtKB/Swiss-Prot
  GPCR_Rhodpsn UniProtKB/Swiss-Prot
  GPCR_Rhodpsn_7TM UniProtKB/Swiss-Prot
KEGG Report hsa:886 UniProtKB/Swiss-Prot
NCBI Gene 886 ENTREZGENE
OMIM 118444 OMIM
PANTHER CHOLECYSTOKININ RECEPTOR TYPE A UniProtKB/Swiss-Prot
  G-PROTEIN COUPLED RECEPTOR UniProtKB/Swiss-Prot
Pfam 7tm_1 UniProtKB/Swiss-Prot
  CholecysA-Rec_N UniProtKB/Swiss-Prot
PharmGKB PA26142 PharmGKB
PRINTS CCYSTOKININR UniProtKB/Swiss-Prot
  CCYSTOKNINAR UniProtKB/Swiss-Prot
  GPCRRHODOPSN UniProtKB/Swiss-Prot
PROSITE G_PROTEIN_RECEP_F1_1 UniProtKB/Swiss-Prot
  G_PROTEIN_RECEP_F1_2 UniProtKB/Swiss-Prot
SMART 7TM_GPCR_Srsx UniProtKB/Swiss-Prot
Superfamily-SCOP Family A G protein-coupled receptor-like UniProtKB/Swiss-Prot
UniProt B2R9Z5 ENTREZGENE
  CCKAR_HUMAN UniProtKB/Swiss-Prot, ENTREZGENE
UniProt Secondary B2R9Z5 UniProtKB/Swiss-Prot